Sort   by:  
 Page size 
UnknownSensory Effects of Menthol and Nicotine in an E-Cigarette.
Not available
S-EPMC4902888 | biostudies-literature
UnknownStructure of the wild-type human BCL6 POZ domain.
Not available
S-EPMC2593701 | biostudies-literature
UnknownUpdated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib.
Not available
S-EPMC7810649 | biostudies-literature
UnknownPatient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial.
Not available
S-EPMC3668468 | biostudies-literature
UnknownIntermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours.
Not available
S-EPMC3929885 | biostudies-literature
UnknownA phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design.
Not available
S-EPMC8362713 | biostudies-literature
UnknownATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
Not available
S-EPMC8099745 | biostudies-literature
UnknownARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer.
Not available
S-EPMC6839905 | biostudies-literature
UnknownHypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial.
Not available
S-EPMC4363524 | biostudies-literature
UnknownEnzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study.
Not available
S-EPMC8360194 | biostudies-literature
Sort   by:  
 Page size